+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Acne Treatment Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6100991
The acne treatment market size was valued at USD 10.59 Billion in 2024, driven by rising acne prevalence and innovations in combination treatments, across the 8 major markets. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2025-2034, to achieve a value of USD 17.09 Billion by 2034.

Acne Treatment Market Overview

Acne, a prevalent skin issue resulting from blocked pores, bacteria, and hormonal shifts, impacts a diverse population including teenagers and adults, leading to a need for successful remedies. The market for acne treatment is growing as consumers look for different options, driven by developments in focused treatments, preferences for natural ingredients, and easy access to over-the-counter products. Developments such as combining different therapies and advancements in technology are influencing the market trends to be focused more on consumers and addressing changing skincare needs.

Acne Treatment Market Growth Drivers

Rising Prevalence of Acne Among Adolescents and Adults Drives Market Growth

Acne is a common skin issue that impacts about 80% of teenagers, with 20% having moderate to severe forms. Moreover, nearly 40% of adults worldwide are affected by adult acne. The significant demand for diverse and efficient treatments, driven by high prevalence in all age groups is fueling market expansion. Moreover, companies are also creating solutions for various age-specific and severity requirements.

Acne Treatment Market Trends

Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.

Increased in Combined Treatment Set to Boost the Market Value

Combining topical and oral treatments in therapy is becoming more popular due to its improved effectiveness and fewer side effects. In October 2023, the FDA approved CABTREO, a topical medication made by Bausch Health that makes treating acne easier by mixing antibiotic, retinoid, and antibacterial properties. It results in almost 50% success in treatment and a 75% decrease in lesions during trials.

Increased Demand for Natural and Organic Products Influences the Market Landscape Significantly

Consumers are increasingly turning to natural, organic, and chemical-free acne treatments, viewing them as more secure. This trend drives growth by encouraging brands to develop and grow in natural skincare, drawing in environmentally conscious consumers and enhancing market dominance.

Growth in Prescription and OTC Skincare Products Boost the Acne Treatment Market Demand

The growing demand for convenient acne treatments is causing an increase in the need for both prescribed and over-the-counter products. The presence in pharmacies and retail stores boosts market interest, providing choices for all levels of acne and expanding the customer base.

Innovation in Technological Advancements in Treatment Options

Technological advancements such as laser and light treatments offer successful options for difficult acne and scarring, drawing clients to high-end dermatology practices. These cutting-edge therapies cater to the high-end market, fulfilling the need for innovative medical attention.

Acne Treatment Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Drug Class:

  • Retinoids
  • Antibiotics
  • Isotretinoin
  • Others

Market Breakup by Treatment Type:

  • Therapeutic Treatments
  • Devices

Market Breakup by Acne Type:

  • Inflammatory
  • Non-inflammatory

Market Breakup by Age Group:

  • 1 to 17 Years
  • 18 to 44 Years
  • 45 to 64 Years
  • 65 Years & Above

Market Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Independent Retail Pharmacies
  • Online Pharmacies
  • Others

Market Breakup by Route of Administration

  • Oral
  • Topical
  • Others

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Acne Treatment Market Share

Market Segmentation Based on the Route of Administration Set to Witness Substantial Growth

The market is segmented into oral, topical, and others based on the route of administration. Among these, the topical segment is expected to dominate the market due to its focused application, reduced side effects, and meeting consumer needs for convenient solutions. The significant market growth is fueled by a strong demand for innovative brands in this category, leading to expanded product offerings and increased market share from repeat buyers.

Acne Treatment Market Analysis by Region

Based on region, the market report covers the United States, EU-4, and the United Kingdom (Germany, France, Italy, Spain, United Kingdom), Japan, and India. Among these, the United States is expected to dominate the market because of the prevalence rate of acne among teenagers and young adults, resulting in a steady need for treatments. Consumers are very conscious of skincare trends, leading to increased interest in both prescription and over-the-counter products. Moreover, the advanced healthcare system, including a wide range of dermatologists and important stakeholders, contributes to the treatment of acne. Government support propels market growth through clinical research and adopting innovative treatment methods such as combination therapies.

Leading Players in the Acne Treatment Market

The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

GSK plc

GSK plc is a global healthcare and pharmaceutical company, headquartered in Brentford, UK. The company has a critical presence in the acne treatment market, through PanOxyl, an over-the-counter product containing benzoyl peroxide, which helps reduce acne-causing bacteria and inflammation.

Pfizer Inc

Pfizer Inc. is a global biotechnology and pharmaceutical leader based in New York. The company offers various acne treatments such as Doxycycline, an oral antibiotic designed for moderate to severe acne. This therapy decreases inflammation and bacterial proliferation, aiding patients requiring increased medical attention.

Johnson & Johnson

Johnson & Johnson is a global healthcare company based in New Jersey, United States. The focus of the company is on products such as Neutrogena Oil-Free Acne Wash and Rapid Clear Stubborn Acne Spot Gel. Having a wide presence in the consumer market enables the company to contribute to making OCT acne treatment more accessible.

Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd is a global pharmaceutical company based in Mumbai, India. Their key portfolio includes products like Aczone, a topical gel used for acne, which helps reduce inflammation and bacterial growth.

Other companies include Galderma, Abbvie Inc., Vyne Therapeutics, Valeant Pharmaceuticals, Almirall, S.A., and Candela Medical.

Key Questions Answered in the Acne Treatment Market

  • What was the acne treatment market value in 2024?
  • What is the acne treatment market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is the market segmentation based on the drug class?
  • What is the market segmentation based on the treatment type?
  • What is the market segmentation based on the acne type?
  • What is the market breakup based on the age group?
  • What is the market breakup based on the route of administration?
  • What is the market segmentation based on the distribution channel?
  • What are the major factors aiding the acne treatment market demand?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • What are the major acne treatment market trends?
  • How does the rise in the geriatric population impact the market size?
  • Who are the key players involved in the acne treatment market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
  • How do antibiotics contribute to acne treatment effectiveness?
  • How effective are acne treatments for the 1 to 17-year age group?
  • Why are topical treatments preferred by many consumers?
  • Why are retail pharmacies a popular choice for acne products?
  • Why does the United States lead in the acne treatment market?
  • What is the market share of acne treatments in EU-4 countries and the UK?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Acne Treatment Market Overview - 8 Major Markets
3.1 Acne Treatment Market Historical Value (2018-2024)
3.2 Acne Treatment Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Acne Treatment Overview
5.1 Guidelines and Stages
5.2 Pathophysiology
5.3 Screening and Diagnosis
5.4 Treatment Pathway
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
6.3 Risk Assessment and Treatment Success Rate
7 Acne Treatment Market - Epidemiology Scenario and Forecast - 8 Major Markets
7.1 8MM Epidemiology Scenario Overview (2018-2034)
7.2 Prevalence, by Country
7.2.1 United States
7.2.2 United Kingdom
7.2.3 EU4
7.2.4 India
7.2.5 Japan
7.3 Diagnosed Cases, by Country
7.3.1 United States
7.3.2 United Kingdom
7.3.3 EU4
7.3.4 India
7.3.5 Japan
7.4 Treatment Seeking Rate, by Country
7.4.1 United States
7.4.2 United Kingdom
7.4.3 EU4
7.4.4 India
7.4.5 Japan
8 Acne Treatment Market Landscape - 8 Major Markets
8.1 Acne Treatment Market: Developers Landscape
8.1.1 Analysis by Year of Establishment
8.1.2 Analysis by Company Size
8.1.3 Analysis by Region
8.2 Acne Treatment Market: Product Landscape
8.2.1 Analysis by Drug Class
8.2.2 Analysis by Treatment Type
8.2.3 Analysis by Route of Administration
9 Acne Treatment Market Challenges and Unmet Needs
9.1 Treatment Pathway Challenges
9.2 Compliance and Drop-Out Analysis
9.3 Awareness and Prevention Gaps
10 Cost of Treatment
11 Acne Treatment Market Dynamics
11.1 Market Drivers and Constraints
11.2 SWOT Analysis
11.2.1 Strengths
11.2.2 Weaknesses
11.2.3 Opportunities
11.2.4 Threats
11.3 PESTEL Analysis
11.3.1 Political
11.3.2 Economic
11.3.3 Social
11.3.4 Technological
11.3.5 Legal
11.3.6 Environment
11.4 Porter’s Five Forces Model
11.4.1 Bargaining Power of Suppliers
11.4.2 Bargaining Power of Buyers
11.4.3 Threat of New Entrants
11.4.4 Threat of Substitutes
11.4.5 Degree of Rivalry
11.5 Key Demand Indicators
11.6 Key Price Indicators
11.7 Industry Events, Initiatives, and Trends
11.8 Value Chain Analysis
12 Acne Treatment Market Segmentation (218-2034) - 8 Major Markets
12.1 Acne Treatment Market (2018-2034) by Drug Class
12.1.1 Market Overview
12.1.2 Retinoids
12.1.3 Antibiotics
12.1.4 Isotretinoin
12.1.5 Others
12.2 Acne Treatment Market (2018-2034) by Treatment Type
12.2.1 Market Overview
12.2.2 Therapeutic Treatments
12.2.3 Devices
12.3 Acne Treatment Market (2018-2034) by Acne Type
12.3.1 Market Overview
12.3.2 Inflammatory
12.3.3 Non-inflammatory
12.4 Acne Treatment Market (2018-2034) by Age Group
12.4.1 Market Overview
12.4.2 1 to 17 Years
12.4.3 18 to 44 Years
12.4.4 45 to 64 Years
12.4.5 65 Years & Above
12.5 Acne Treatment Market (2018-2034) by Distribution Channel
12.5.1 Market Overview
12.5.2 Hospital Pharmacies
12.5.3 Independent Retail Pharmacies
12.5.4 Online Pharmacies
12.5.5 Others
12.6 Acne Treatment Market (2018-2034) by Route of Administration
12.6.1 Market Overview
12.6.2 Oral
12.6.3 Topical
12.6.4 Others
12.7 Acne Treatment Market (2018-2034) by Region
12.7.1 Market Overview
12.7.2 United States
12.7.3 EU-4 and the United Kingdom
12.7.3.1 Germany
12.7.3.2 France
12.7.3.3 Italy
12.7.3.4 Spain
12.7.3.5 United Kingdom
12.7.4 Japan
12.7.5 India
13 United States Acne Treatment Market (218-2034)
13.1 United States Acne Treatment Market (2018-2034) by Drug Class
13.1.1 Market Overview
13.1.2 Retinoids
13.1.3 Antibiotics
13.1.4 Isotretinoin
13.1.5 Others
13.2 United States Acne Treatment Market (2018-2034) by Treatment Type
13.2.1 Market Overview
13.2.2 Therapeutic Treatments
13.2.3 Devices
13.3 United States Acne Treatment Market (2018-2034) by Acne Type
13.3.1 Market Overview
13.3.2 Inflammatory
13.3.3 Non-inflammatory
13.4 United States Acne Treatment Market (2018-2034) by Age Group
13.4.1 Market Overview
13.4.2 1 to 17 Years
13.4.3 18 to 44 Years
13.4.4 45 to 64 Years
13.4.5 65 Years & Above
13.5 United States Acne Treatment Market (2018-2034) by Distribution Channel
13.5.1 Market Overview
13.5.2 Hospital Pharmacies
13.5.3 Independent Retail Pharmacies
13.5.4 Online Pharmacies
13.5.5 Others
13.6 United States Acne Treatment Market (2018-2034) by Route of Administration
13.6.1 Market Overview
13.6.2 Oral
13.6.3 Topical
13.6.4 Others
14 EU-4 and United Kingdom Acne Treatment Market (218-2034)
14.1 EU-4 and United Kingdom Acne Treatment Market (2018-2034) by Drug Class
14.1.1 Market Overview
14.1.2 Retinoids
14.1.3 Antibiotics
14.1.4 Isotretinoin
14.1.5 Others
14.2 EU-4 and United Kingdom Acne Treatment Market (2018-2034) by Treatment Type
14.2.1 Market Overview
14.2.2 Therapeutic Treatments
14.2.3 Devices
14.3 EU-4 and United Kingdom Acne Treatment Market (2018-2034) by Acne Type
14.3.1 Market Overview
14.3.2 Inflammatory
14.3.3 Non-inflammatory
14.4 EU-4 and United Kingdom Acne Treatment Market (2018-2034) by Age Group
14.4.1 Market Overview
14.4.2 1 to 17 Years
14.4.3 18 to 44 Years
14.4.4 45 to 64 Years
14.4.5 65 Years & Above
14.5 EU-4 and United Kingdom Acne Treatment Market (2018-2034) by Distribution Channel
14.5.1 Market Overview
14.5.2 Hospital Pharmacies
14.5.3 Independent Retail Pharmacies
14.5.4 Online Pharmacies
14.5.5 Others
14.6 EU-4 and United Kingdom Acne Treatment Market (2018-2034) by Route of Administration
14.6.1 Market Overview
14.6.2 Oral
14.6.3 Topical
14.6.4 Others
15 Japan Acne Treatment Market (218-2034)
15.1 Japan Acne Treatment Market (2018-2034) by Drug Class
15.1.1 Market Overview
15.1.2 Retinoids
15.1.3 Antibiotics
15.1.4 Isotretinoin
15.1.5 Others
15.2 Japan Acne Treatment Market (2018-2034) by Treatment Type
15.2.1 Market Overview
15.2.2 Therapeutic Treatments
15.2.3 Devices
15.3 Japan Acne Treatment Market (2018-2034) by Acne Type
15.3.1 Market Overview
15.3.2 Inflammatory
15.3.3 Non-inflammatory
15.4 Japan Acne Treatment Market (2018-2034) by Age Group
15.4.1 Market Overview
15.4.2 1 to 17 Years
15.4.3 18 to 44 Years
15.4.4 45 to 64 Years
15.4.5 65 Years & Above
15.5 Japan Acne Treatment Market (2018-2034) by Distribution Channel
15.5.1 Market Overview
15.5.2 Hospital Pharmacies
15.5.3 Independent Retail Pharmacies
15.5.4 Online Pharmacies
15.5.5 Others
15.6 Japan Acne Treatment Market (2018-2034) by Route of Administration
15.6.1 Market Overview
15.6.2 Oral
15.6.3 Topical
15.6.4 Others
16 India Acne Treatment Market (218-2034)
16.1 India Acne Treatment Market (2018-2034) by Drug Class
16.1.1 Market Overview
16.1.2 Retinoids
16.1.3 Antibiotics
16.1.4 Isotretinoin
16.1.5 Others
16.2 India Acne Treatment Market (2018-2034) by Treatment Type
16.2.1 Market Overview
16.2.2 Therapeutic Treatments
16.2.3 Devices
16.3 India Acne Treatment Market (2018-2034) by Acne Type
16.3.1 Market Overview
16.3.2 Inflammatory
16.3.3 Non-inflammatory
16.4 India Acne Treatment Market (2018-2034) by Age Group
16.4.1 Market Overview
16.4.2 1 to 17 Years
16.4.3 18 to 44 Years
16.4.4 45 to 64 Years
16.4.5 65 Years & Above
16.5 India Acne Treatment Market (2018-2034) by Distribution Channel
16.5.1 Market Overview
16.5.2 Hospital Pharmacies
16.5.3 Independent Retail Pharmacies
16.5.4 Online Pharmacies
16.5.5 Others
16.6 India Acne Treatment Market (2018-2034) by Route of Administration
16.6.1 Market Overview
16.6.2 Oral
16.6.3 Topical
16.6.4 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.2 US FDA
17.3 EU EMA
17.4 Japan PMDA
17.5 India CDSCO
17.6 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication Year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Grants Analysis
20.1 Analysis by Year
20.2 Analysis by Amount Awarded
20.3 Analysis by Issuing Authority
20.4 Analysis by Grant Application
20.5 Analysis by Funding Institute
20.6 Analysis by NIH Departments
20.7 Analysis by Recipient Organization
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Drug Class of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Strategic Initiatives
22.1 Analysis by Partnership Instances
22.2 Analysis by Drug Class of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Market Share Analysis, By Region (Top 5 Companies)
23.2 Galderma
23.2.1 Financial Analysis
23.2.2 Treatment Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Company News and Development
23.2.5 Certifications
23.3 Abbvie Inc.
23.3.1 Financial Analysis
23.3.2 Treatment Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Company News and Development
23.3.5 Certifications
23.4 Johnson & Johnson
23.4.1 Financial Analysis
23.4.2 Treatment Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Company News and Development
23.4.5 Certifications
23.5 GSK plc
23.5.1 Financial Analysis
23.5.2 Treatment Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Company News and Development
23.5.5 Certifications
23.6 Sun Pharmaceutical Industries Ltd.
23.6.1 Financial Analysis
23.6.2 Treatment Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Company News and Development
23.6.5 Certifications
23.7 Pfizer Inc.
23.7.1 Financial Analysis
23.7.2 Treatment Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Company News and Development
23.7.5 Certifications
23.8 Vyne Therapeutics
23.8.1 Financial Analysis
23.8.2 Treatment Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Company News and Development
23.8.5 Certifications
23.9 Valeant Pharmaceuticals
23.9.1 Financial Analysis
23.9.2 Treatment Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Company News and Development
23.9.5 Certifications
23.10 Almirall, S.A
23.10.1 Financial Analysis
23.10.2 Treatment Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Company News and Development
23.10.5 Certifications
23.11 Candela Medical
23.11.1 Financial Analysis
23.11.2 Treatment Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Company News and Development
23.11.5 Certifications
24 Acne Treatment Market - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket

Companies Mentioned

  • GSK plc
  • Pfizer Inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd.

Table Information